Budesonide Inhalation Suspension
Award Notice Posted
- Solicitation number
- SPE2D2-18-R-0025
- Agency
-
Defense Logistics Agency
Department of Defense
- Awarded
- to Exelan Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D2-19-D-0075 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
Defense Logistics Agency awarded Exelan Pharmaceuticals a contract for Budesonide Inhalation Suspension on July 1, 2019 for $40,400,530.45 with no set-aside designation. This Award Notice from DLA grants Exelan Pharmaceuticals the contract to supply Budesonide Inhalation Suspension, a medication used to treat asthma, for an initial value of over $40 million.
Notice text
2 versions
Update #2 · Latest ·
Awarded contract SPE2D2-19-D-0075 to Exelan Pharmaceuticals for $40,400,530.45 on 2024-07-01.
Update #1 ·
Awarded contract SPE2D2-19-D-0075 to Exelan Pharmaceuticals for $40,400,530.45 on 2019-07-01.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Budesonide Inhalation Suspension National Contract SPE2D218R0025 | Solicitation | |
| Budesonide Inhalation Suspension | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity